Sogroya 10MG/1.5ML1 Pen
Sogroya 10 MG/1.5ML 1 Pen contains a derivative of human growth hormone; it helps compensate for growth hormone deficiency and treat growth failure in children.
Sogroya ingredients
Sogroya injections contain the active ingredient somapacitan, a long-acting recombinant human growth hormone derivative. It works similarly to human growth hormone, which supports the growth of bones and muscles.
Indications for Use of Sogroya
Sogroya is used for:
-
Treating growth hormone deficiency in children aged 3 years and older.
-
Adolescents with growth failure caused by growth hormone deficiency.
-
Adults with growth hormone deficiency.
Sogroya dose
-
The dose varies depending on age.
-
For children: doses start at 0.16 mg per kilogram of body weight per week.
-
For adults: doses range between 1.5 – 2 mg per week.
-
Sogroya is administered once weekly.
-
It is injected subcutaneously into the abdomen, thigh, or upper arm.
-
The injection site should be rotated each time.
Side Effects of Sogroya
Sogroya injections may cause some side effects, such as:
-
Headache.
-
Hypothyroidism.
-
Elevated blood sugar levels.
-
Joint pain.
-
Swelling of the extremities.
-
Fatigue.
-
Pain, swelling, or redness at the injection site.
Contraindications
Sogroya pen should not be used in cases of:
-
Hypersensitivity to its components.
-
Any evidence of active cancer.
-
Children with closed epiphyses (growth plates).
-
Severe illness, post-surgical complications, acute respiratory failure, or similar conditions.
-
Pregnancy.
Drug Interactions
Consult a doctor or pharmacist before using Sogroya alongside any other medication, especially:
-
Corticosteroids.
-
Oral estrogens.
-
Diabetes medications.
-
Thyroid hormones.
-
Epilepsy medications.
Storage Instructions
-
Keep out of reach of children.
-
Store in a refrigerator at 2 – 8°C.
-
Do not freeze.
-
If refrigeration is not possible, it may be stored at room temperature (up to 30°C) for a maximum of 72 hours.
-
Keep in its original packaging, protected from light.